Combination antiretroviral therapy (ART) to treat human immunodeficiency virus (HIV)
infection has proven remarkably successful–for those who can access and afford it–yet HIV …

In this brief review and perspective, we address the question of whether the immune
responses that bring about immune control of acute HIV infection are the same as, or distinct …

Gut microbiota dysbiosis features progressive HIV infection and is a potential target for
intervention. Herein, we explored the microbiome of 16 elite controllers (EC), 32 …

Background: The proportion of HIV controllers developing virologic, immunological or
clinical progression and the baseline predictors of these outcomes have not been assessed …

The objective of this paper is to study shedding patterns of cows infected with
Mycobacterium avium subsp. paratuberculosis (MAP). While multiple single farm studies of …

Some HIV controllers (HICs) experience CD4+ T cell count loss and/or lose their ability to
control HIV. In this study, we investigated the rate of immunologic and/or virologic …

Objectives: This analysis assessed the impact of undisclosed HIV infection and antiretroviral
therapy (ART) on national estimates of diagnosed HIV and ART coverage in Kenya …

A small subset of HIV-1 infected individuals, the" Elite Controllers"(EC), can control viral
replication and restrain progression to immunodeficiency without antiretroviral therapy …

Objectives: HIV-1-infected persons spontaneously controlling viremia without treatment
(SCV) are rare. Sex and race effects on prevalence and outcome are poorly defined, and it is …

Background Human immunodeficiency virus controllers (HICs) form a heterogeneous group
of patients with regard to formal definitions, immunologic characteristics, and changes over …